1. Cleland JG, Clark AL. Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth. J Am Coll Cardiol 2003; 42: 1234-7.
2. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-80.
3. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-53.
4. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003; 289: 2685-94.
5. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-38.
6. Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl Med 2010; 363: 2385-95.
7. Goldenberg I, Kutyifa V, Klein HU, et al. Survival with cardiac resynchronization therapy in mild heart failure. N Engl J Med 2014; 370: 1694-701.
8. Chen K, Su H, Xie C, et al. Prognostic implications of QRS duration in third-degree atrioventricular block patients with heart failure treated with cardiac resynchronization therapy. Int Heart J 2018; 59: 1320-6.
9. Daubert C, Behar N, Martins RP, et al. Avoiding non-responders to cardiac resynchronization therapy: a practical guide. Eur Heart J. 2017; 38: 1463-72.
10. Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999; 99: 2993- 3001.
11. Saxon LA, Ellenbogen KA. Resynchronization therapy for the treatment of heart failure. Circulation 2003; 108: 1044-8.
12. Verma N, Boehmer J, Bhargava K, et al. Evaluation, Management, and Outcomes of patients poorly responsive to cardiac resynchronization device therapy. J Am Coll Cardiol. 2019; 74: 2588-603.
13. Martin DO, Lemke B, Birnie D, et al. Investigation of a novel algorithm for synchronized left- ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm 2012; 9: 1807-14.
14. Verma N, O’Donnell D, Bassiouny M, et al. Programming cardiac resynchronization therapy for electrical synchrony: reaching beyond left bundle branch block and left ventricular activation delay. J Am Heart Assoc. 2018; 7: e007489.
15. Belardinelli R, Ciampani N, Costantini C, Blandini A, Purcaro A. Comparison of impedance cardiography with thermodilution and direct Fick methods for noninvasive measurement of stroke volume and cardiac output during incremental exercise in patients with ischemic cardiomyopathy. Am J Cardiol 1996; 77: 1293-301.
16. Raphael CE, Kyriacou A, Jones S, et al. Multinational evaluation of the interpretability of the iterative method of optimization of AV delay for CRT. Int J Cardiol 2013; 168: 407-13.
17. Drazner MH, Thompson B, Rosenberg PB, et al. Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2002; 89: 993-5.
18. Ovsyshcher I, Zimlichman R, Katz A, Bondy C, Furman S. Measurements of cardiac output by impedance cardiography in pacemaker patients at rest: effects of various atrioventricular delays. J Am Coll Cardiol 1993; 21: 761-7.
19. Ovsyshcher I, Furman S. Impedance cardiography for cardiac output estimation in pacemaker patients: review of the literature. Pacing Clin Electrophysiol 1993; 16: 1412-22.
20. Braun MU, Schnabel A, Rauwolf T, Schulze M, Strasser RH. Impedance cardiography as a noninvasive technique for atrioventricular interval optimization in cardiac resynchronization therapy. J Interv Card Electrophysiol 2005; 13: 223-9.
21. Heinroth KM, Elster M, Nuding S, et al. Impedance cardiography: A useful and reliable tool in optimization of cardiac resynchronization devices. Europace 2007; 9: 744-50.
22. Fortin J, Haitchi G, Bojic A. Validation and verification of the Task ForceⓇ Monitor. Results of clinical studies for FDA 2001; 510: 014063.
23. Mercado P, Maizel J, Beyls C, et al. Transthoracic echocardiography: an accurate and precise method for estimating cardiac output in the critically ill patient. Crit Care. 2017; 21: 136. doi: 10.1186/s13054-017-1737-7.
24. TSE H-F, Yu C, Park E, et al. Impedance cardiography for atrioventricular interval optimization during permanent left ventricular pacing. Pacing Clin Electrophysiol. 2003; 26: 189-91.
25. Rossi R, Muia N, Turco V, Sgura FA, Molinari R, Modena MG. Short atrioventricular delay reduces the degree of mitral regurgitation in patients with a sequential dual-chamber pacemaker. Am J Cardiol 1997; 80: 901-5.
26. Gorcsan J III, Abraham T, Agler DA, et al. Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting-a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr 2008; 21: 191-213.
27. Kedia N, Ng K, Apperson-Hansen C, et al. Usefulness of atrioventricular delay optimization using Doppler assessment of mitral inflow in patients undergoing cardiac resynchronization therapy. Am J Cardiol 2006; 98: 780-5.
28. Ypenburg C, van Bommel RJ, Borleffs CJ, et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol. 2009; 53: 483-90.
29. Auricchio A, Ding J, Spinelli JC, et al. Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay. J Am Coll Cardiol 2002; 39: 1163-9.
30. Turcott RG, Witteles RM, Wang PJ, Vagelos RH, Fowler MB, Ashley EA. Measurement precision in the optimization of cardiac resynchronization therapy. Circ Heart Fail 2010; 3: 395-404.
31. Kerlan JE, Sawhney NS, Waggoner AD, et al. Prospective comparison of echocardiographic atrioventricular delay optimization methods for cardiac resynchronization therapy. Heart Rhythm 2006; 3: 148-54.
32. Leon AR, Abraham WT, Brozena S, et al. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. J Am Coll Cardiol 2005;46: 2298–304.
33. Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002; 40: 1615–22.
34. London GM, Guerin AP. Influence of arterial pulse and reflected waves on blood pressure and cardiac function. Am Heart J 1999;138:220-4
35. Schieken RM, Patel MR, Falsetti HL, Lauer RM. Effect of mitral valvular regurgitation on transthoracic impedance cardiogram. Br Heart J 1981; 45: 166-72.
36. van der Meer NJ, Vonk Noordegraaf A, Kamp O, de Vries PM. Noninvasive measurement of cardiac output: two methods compared in patients with mitral regurgitation. Angiology 1999; 50: 95-101.
37. Verma N, Stadler RW, Ghosh S, et al. Influence of automatic frequent pace-timing adjustments on effective left ventricular pacing during cardiac resynchronization therapy. Europace. 2017; 19: 831- 7.